Advertisement

Molecular Neurobiology

, Volume 56, Issue 7, pp 4730–4740 | Cite as

Anti-vasospastic Effects of Epidermal Growth Factor Receptor Inhibitors After Subarachnoid Hemorrhage in Mice

  • Fumi Nakano
  • Fumihiro Kawakita
  • Lei Liu
  • Yoshinari Nakatsuka
  • Hirofumi Nishikawa
  • Takeshi Okada
  • Hideki Kanamaru
  • Sujon Pak
  • Masato Shiba
  • Hidenori SuzukiEmail author
Article

Abstract

Subarachnoid hemorrhage (SAH) is a devastating disease. Cerebral vasospasm is still an important cause of post-SAH poor outcomes, but its mechanisms remain unveiled. Activation of epidermal growth factor receptor (EGFR) is suggested to cause vasoconstriction in vitro, but no report has demonstrated the involvement of EGFR in vasospasm development after SAH in vivo. Cross-talk of EGFR and vascular endothelial growth factor (VEGF) receptor, which may affect post-SAH vasospasm, was also reported in cancer cells, but has not been demonstrated in post-SAH vasospasm. The aim of this study was to investigate whether EGFR as well as EGFR-VEGF receptor cross-talk engage in the development of cerebral vasospasm in a mouse SAH model. C57BL6 mice underwent endovascular perforation SAH or sham modeling. At 30 min post-modeling, mice were randomly administrated vehicle or 2 doses of selective EGFR inhibitors intracerebroventricularly. A higher dose of the inhibitor significantly prevented post-SAH neurological impairments at 72 h and vasospasm at 24 h associated with suppression of post-SAH activation of EGFR and extracellular signal-regulated kinase (ERK) 1/2 in the cerebral artery wall, especially in the smooth muscle cell layers. Anti-EGFR neutralizing antibody also showed similar effects. However, neither expression levels of VEGF nor activation levels of a major receptor of VEGF, VEGF receptor-2, were affected by SAH and two kinds of EGFR inactivation. Thus, this study first showed that EGFR-ERK1/2 pathways may be involved in post-SAH vasospasm development, and that EGFR-VEGF receptor cross-talk may not play a significant role in the development of vasospasm in mice.

Keywords

Epidermal growth factor receptor Extracellular signal-regulated kinase 1/2 Subarachnoid hemorrhage Vascular endothelial growth factor Vasospasm 

Notes

Acknowledgments

We thank Ms. Chiduru Yamamoto-Nakamura (Department of Neurosurgery, Mie University Graduate School of Medicine) for her assistance with administrative support.

Funding

This study was funded by a grant-in-aid for Scientific Research from Japan Society for the Promotion of Science to Drs. Suzuki [17K10825] and Shiba [17K16640].

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Research Involving Animals

All procedures were approved by the Animal Ethics Review Committee of Mie University and were carried out according to the institution’s Guidelines for Animal Experiments.

Supplementary material

12035_2018_1400_MOESM1_ESM.pdf (9.5 mb)
ESM 1 (PDF 9712 kb)

References

  1. 1.
    Suzuki H, Shiba M, Nakatsuka Y, Nakano F, Nishikawa H (2017) Higher cerebrospinal fluid pH may contribute to the development of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Transl Stroke Res 8:165–173PubMedGoogle Scholar
  2. 2.
    Fujimoto M, Shiba M, Kawakita F, Liu L, Shimojo N, Imanaka-Yoshida K, Yoshida T, Suzuki H (2018) Effects of tenascin-C knockout on cerebral vasospasm after experimental subarachnoid hemorrhage in mice. Mol Neurobiol 55:1951–1958PubMedGoogle Scholar
  3. 3.
    Borel CO, McKee A, Parra A, Haglund MM, Solan A, Prabhakar V, Sheng H, Warner DS et al (2003) Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage. Stroke 34:427–433PubMedGoogle Scholar
  4. 4.
    McGirt MJ, Lynch JR, Blessing R, Warner DS, Friedman AH, Laskowitz DT (2002) Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 51:1128–1135PubMedGoogle Scholar
  5. 5.
    Yan J, Chen C, Lei J, Yang L, Wang K, Liu J, Zhou C (2006) 2-methoxyestradiol reduces cerebral vasospasm after 48 hours of experimental subarachnoid hemorrhage in rats. Exp Neurol 202:348–356PubMedGoogle Scholar
  6. 6.
    Midwood KS, Hussenet T, Langlois B, Orend G (2011) Advances in tenascin-C biology. Cell Mol Life Sci 68:3175–3199PubMedPubMedCentralGoogle Scholar
  7. 7.
    Suzuki H, Kinoshita N, Imanaka-Yoshida K, Yoshida T, Taki W (2008) Cerebrospinal fluid tenascin-C increased preceding the development of chronic shunt-dependent hydrocephalus after subarachnoid hemorrhage. Stroke 39:1610–1612PubMedGoogle Scholar
  8. 8.
    Fujimoto M, Shiba M, Kawakita F, Liu L, Nakasaki A, Shimojo N, Imanaka-Yoshida K, Yoshida T et al (2016) Epidermal growth factor-like repeats of tenascin-C-induced constriction of cerebral arteries via activation of epidermal growth factor receptors in rats. Brain Res 1642:436–444PubMedGoogle Scholar
  9. 9.
    Kawanabe Y, Masaki T, Hashimoto N (2004) Involvement of epidermal growth factor receptor-protein tyrosine kinase transactivation in endothelin-1-induced vascular contraction. J Neurosurg 100:1066–1071PubMedGoogle Scholar
  10. 10.
    Liu L, Fujimoto M, Kawakita F, Nakano F, Imanaka-Yoshida K, Yoshida T, Suzuki H (2016) Anti-vascular endothelial growth factor treatment suppressed early brain injury after subarachnoid hemorrhage in mice. Mol Neurobiol 53:4529–4538PubMedGoogle Scholar
  11. 11.
    Ray L, Mathieu M, Jespers P, Hadad I, Mahmoudabady M, Pensis A, Motte S, Peters IR et al (2008) Early increase in pulmonary vascular reactivity with overexpression of endothelin-1 and vascular endothelial growth factor in canine experimental heart failure. Exp Physiol 93:434–442PubMedGoogle Scholar
  12. 12.
    Adeoye OO, Butler SM, Hubbell MC, Semotiuk A, Williams JM, Pearce WJ (2013) Contribution of increased VEGF receptors to hypoxic changes in fetal ovine carotid artery contractile proteins. Am J Physiol Cell Physiol 304:C656–C665PubMedPubMedCentralGoogle Scholar
  13. 13.
    Larsen AK, Ouaret D, El Ouadrani K, Petitprez A (2011) Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis. Pharmacol Ther 131:80–90PubMedGoogle Scholar
  14. 14.
    Shim JW, Madsen JR (2018) VEGF signaling in neurological disorders. Int J Mol Sci 19:275PubMedCentralGoogle Scholar
  15. 15.
    Shim JW, Sandlund J, Hameed MQ, Blazer-Yost B, Zhou FC, Klagsbrun M, Madsen JR (2016) Excess HB-EGF, which promotes VEGF signaling, leads to hydrocephalus. Sci Rep 6:26794PubMedPubMedCentralGoogle Scholar
  16. 16.
    Li XM, Su F, Ji MH, Zhang GF, Qiu LL, Jia M, Gao J, Xie Z et al (2014) Disruption of hippocampal neuregulin 1-ErbB4 signaling contributes to the hippocampus-dependent cognitive impairment induced by isoflurane in aged mice. Anesthesiology 121:79–88PubMedPubMedCentralGoogle Scholar
  17. 17.
    Formisano L, D’Amato V, Servetto A, Brillante S, Raimondo L, Di Mauro C, Marciano R, Orsini RC et al (2015) Src inhibitors act through different mechanisms in non-small cell lung cancer models depending on EGFR and RAS mutational status. Oncotarget 6:26090–26103PubMedPubMedCentralGoogle Scholar
  18. 18.
    Kawakita F, Fujimoto M, Liu L, Nakano F, Nakatsuka Y, Suzuki H (2017) Effects of Toll-like receptor 4 antagonists against cerebral vasospasm after experimental subarachnoid hemorrhage in mice. Mol Neurobiol 54:6624–6633PubMedGoogle Scholar
  19. 19.
    Sabri M, Ai J, Knight B, Tariq A, Jeon H, Shang X, Marsden PA, Loch Macdonald R (2011) Uncoupling of endothelial nitric oxide synthase after experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab 31:190–199PubMedGoogle Scholar
  20. 20.
    Schneider CA, Rasband WS, Eliceiri KW (2012) NIH image to image J: 25 years of image analysis. Nat Methods 9:671–675PubMedPubMedCentralGoogle Scholar
  21. 21.
    Karkkainen MJ, Petrova TV (2000) Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene 19:5598–5605PubMedGoogle Scholar
  22. 22.
    Wang WM, Zhao ZL, Ma SR, Yu GT, Liu B, Zhang L, Zhang WF, Kulkarni AB et al (2015) Epidermal growth factor receptor inhibition reduces angiogenesis via hypoxia-inducible factor-1α and Notch1 in head neck squamous cell carcinoma. PLoS One 10:e0119723PubMedPubMedCentralGoogle Scholar
  23. 23.
    Ledón N, Casacó A, Casanova E, Beausoleil I (2011) Comparative analysis of binding affinities to epidermal growth factor receptor of monoclonal antibodies nimotuzumab and cetuximab using different experimental animal models. Placenta 32:531–534PubMedGoogle Scholar
  24. 24.
    Zervas NT, Liszczak TM, Mayberg MR, Black PM (1982) Cerebrospinal fluid may nourish cerebral vessels through pathways in the adventitia that may be analogous to systemic vasa vasorum. J Neurosurg 56:475–481PubMedGoogle Scholar
  25. 25.
    Langheinrich AC, Michniewicz A, Bohle RM, Ritman EL (2007) Vasa vasorum neovascularization and lesion distribution among different vascular beds in ApoE-/-/LDL-/- double knockout mice. Atherosclerosis 191:73–81PubMedGoogle Scholar
  26. 26.
    Bedussi B, van Lier MG, Bartstra JW, de Vos J, Siebes M, VanBavel E, Bakker EN (2015) Clearance from the mouse brain by convection of interstitial fluid towards the ventricular system. Fluids Barriers CNS 12:23PubMedPubMedCentralGoogle Scholar
  27. 27.
    Bedussi B, van der Wel NN, de Vos J, van Veen H, Siebes M, VanBavel E, Bakker EN (2017) Paravascular channels, cisterns, and the subarachnoid space in the rat brain: a single compartment with preferential pathways. J Cereb Blood Flow Metab 37:1374–1385PubMedGoogle Scholar
  28. 28.
    Abbott NJ (2004) Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem Int 45:545–552PubMedGoogle Scholar
  29. 29.
    Makki N, Thiel KW, Miller FJ Jr (2013) The epidermal growth factor receptor and its ligands in cardiovascular disease. Int J Mol Sci 14:20597–20613PubMedPubMedCentralGoogle Scholar
  30. 30.
    Kalmes A, Daum G, Clowes AW (2001) EGFR transactivation in the regulation of SMC function. Ann N Y Acad Sci 947:42–55PubMedGoogle Scholar
  31. 31.
    Kim J, Lee CK, Park HJ, Kim HJ, So HH, Lee KS, Lee HM, Roh HY et al (2006) Epidermal growth factor induces vasoconstriction through the phosphatidylinositol 3-kinase-mediated mitogen-activated protein kinase pathway in hypertensive rats. J Pharmacol Sci 101:135–143PubMedGoogle Scholar
  32. 32.
    Chansel D, Ciroldi M, Vandermeersch S, Jackson LF, Gomez AM, Henrion D, Lee DC, Coffman TM et al (2006) Heparin binding EGF is necessary for vasospastic response to endothelin. FASEB J 20:1936–1938PubMedGoogle Scholar
  33. 33.
    Koide M, Penar PL, Tranmer BI, Wellman GC (2007) Heparin-binding EGF-like growth factor mediates oxyhemoglobin-induced suppression of voltage-dependent potassium channels in rabbit cerebral artery myocytes. Am J Physiol Heart Circ Physiol 293:H1750–H1759PubMedGoogle Scholar
  34. 34.
    Koide M, Wellman GC (2015) SAH-induced MMP activation and K V current suppression is mediated via both ROS-dependent and ROS-independent mechanisms. Acta Neurochir Suppl 120:89–94PubMedPubMedCentralGoogle Scholar
  35. 35.
    Koide M, Wellman GC (2013) SAH-induced suppression of voltage-gated K(+) (K(V)) channel currents in parenchymal arteriolar myocytes involves activation of the HB-EGF/EGFR pathway. Acta Neurochir Suppl 115:179–184PubMedPubMedCentralGoogle Scholar
  36. 36.
    Friedrich B, Müller F, Feiler S, Schöller K, Plesnila N (2012) Experimental subarachnoid hemorrhage causes early and long-lasting microarterial constriction and microthrombosis: an in-vivo microscopy study. J Cereb Blood Flow Metab 32:447–455PubMedGoogle Scholar
  37. 37.
    Liu H, Dienel A, Schöller K, Schwarzmaier SM, Nehrkorn K, Plesnila N, Terpolilli NA (2018) Microvasospasms after experimental subarachnoid hemorrhage do not depend on endothelin A receptors. Stroke 49:693–699PubMedGoogle Scholar
  38. 38.
    Suzuki H, Hasegawa Y, Kanamaru K, Zhang JH (2010) Mechanisms of osteopontin-induced stabilization of blood-brain barrier disruption after subarachnoid hemorrhage in rats. Stroke 41:1783–1790PubMedPubMedCentralGoogle Scholar
  39. 39.
    Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I et al (2011) Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 10:618–625PubMedGoogle Scholar
  40. 40.
    Pore N, Jiang Z, Gupta A, Cerniglia G, Kao GD, Maity A (2006) EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms. Cancer Res 66:3197–3204PubMedGoogle Scholar
  41. 41.
    Miller CA, Lombard FW, Wu CT, Hubbard CJ, Silbajoris L, Borel CO, Niklason LE (2006) Role of vascular mitogens in subarachnoid hemorrhage-associated cerebral vasculopathy. Neurocrit Care 5:215–221PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Fumi Nakano
    • 1
  • Fumihiro Kawakita
    • 1
  • Lei Liu
    • 1
  • Yoshinari Nakatsuka
    • 1
  • Hirofumi Nishikawa
    • 1
  • Takeshi Okada
    • 1
  • Hideki Kanamaru
    • 1
  • Sujon Pak
    • 1
  • Masato Shiba
    • 1
  • Hidenori Suzuki
    • 1
    Email author
  1. 1.Department of NeurosurgeryMie University Graduate School of MedicineTsuJapan

Personalised recommendations